In patients with cardiac arrest (CA) cerebral oximetry has emerged as a real-time indicator of oxygen delivery to the brain which could be used to optimise cerebral oxygenation during and after cardiopulmonary resuscitation (CPR) ( Table 1) . Near-infrared spectroscopy (NIRS) emits infrared light (700-950 nm wavelength), which is not absorbed significantly by melanin in the skin and enables non-invasive monitoring of the regional haemoglobin oxygen saturation in the brain (rSO 2 ). NIRS electrodes are placed on the scalp above the frontal cortex and the sampling volume is located about 2 cm underneath the skull [1] . Since about 70% of the sampled blood is venous, normal rSO 2 is approximately 60-80%. Unlike arterial pulse oximetry, rSO 2 can still be measured when blood flow is nonpulsatile or even absent, enabling NIRS to be used during CA. Unlike the electroencephalogram, NIRS is not susceptible to motion artefact generated by CPR.
In patients with cardiac arrest (CA) cerebral oximetry has emerged as a real-time indicator of oxygen delivery to the brain which could be used to optimise cerebral oxygenation during and after cardiopulmonary resuscitation (CPR) ( Table 1) . Near-infrared spectroscopy (NIRS) emits infrared light (700-950 nm wavelength), which is not absorbed significantly by melanin in the skin and enables non-invasive monitoring of the regional haemoglobin oxygen saturation in the brain (rSO 2 ). NIRS electrodes are placed on the scalp above the frontal cortex and the sampling volume is located about 2 cm underneath the skull [1] . Since about 70% of the sampled blood is venous, normal rSO 2 is approximately 60-80%. Unlike arterial pulse oximetry, rSO 2 can still be measured when blood flow is nonpulsatile or even absent, enabling NIRS to be used during CA. Unlike the electroencephalogram, NIRS is not susceptible to motion artefact generated by CPR.
Use of cerebral oximetry during cardiac arrest
Higher rSO 2 values during CPR are associated with significantly higher rates of return of spontaneous circulation (ROSC). In a review of 26 observational studies , the averaged mean rSO 2 in patients achieving ROSC was 41 ± 12% vs. 30 ± 12% for those without ROSC (p = 0.009) [2] . However, there was wide overlap of rSO 2 values between the two groups. Among 183 in-hospital CA (IHCA) patients [3] , a 25% rSO 2 cutoff predicted no ROSC with 100 [94-100]% specificity, while a 65% rSO 2 cut-off predicted ROSC with 99 [95-100]% specificity. However, these values corresponded to the extremes of the distribution, so that the relevant sensitivities were low (13 [8- As has been observed for end-tidal carbon dioxide (ETCO 2 ), an abrupt increase in rSO 2 values during CPR indicates that ROSC has occurred [5] . In a study on 53 OHCA patients, 22 (42%) had ROSC after a mean of 22.5 min of CPR; when ROSC occurred, the median rSO 2 increased from 22.5% [16-35] to 51% [39-55] in 3 min [6] . A potential advantage of rSO 2 compared with ETCO 2 for monitoring during CPR is that detection of the rSO 2 signal does not require advanced airway management.
In a study on IHCA [3] , time with rSO 2 > 50% during CPR best predicted favourable neurological outcome after resuscitation (cerebral performance category 1-2), suggesting that rSO 2 may reflect the quality of cerebral oxygenation and perfusion during CPR. In another study, among 92 OHCA patients who arrived at the emergency department with ongoing CPR, the rate of neurological recovery was 50% in those with rSO 2 > 40%, 22% in those with rSO 2 26-40%, and 0% in those with rSO 2 25% or less [7] .
Cerebral oximetry in post-resuscitation care
Optimising cerebral oxygenation and perfusion is one of the mainstays of post-resuscitation care. Autoregulation of cerebral blood flow (CBF) is lost in about one third of comatose CA survivors [8] , while in others the *Correspondence: jerry.nolan@nhs.netzone of autoregulation is narrowed and right-shifted [9] so that CBF is maintained consistent and independent from mean arterial pressure (MAP) only within a narrower and higher MAP range. In clinical studies the optimal MAP has been identified as that where the correlation coefficient between rSO 2 and MAP (termed as COX) is minimal in the individual patient [9] . In children resuscitated from CA, deviations from optimal MAP have been associated with worse neurological outcome [8, 10] . In a study on 51 resuscitated comatose adults [9] , the time spent below the optimal MAP was associated with a lower likelihood of survival (OR 0.97 [0.96-0.99], p = 0.02).
Cerebrovascular reactivity to CO 2 is generally preserved after CA and manipulating arterial partial pressure of carbon dioxide (PaCO 2 ) may be used in order to optimise CBF and brain oxygenation. In the recent COMACARE randomised pilot trial [11] , a high-normal (5.8-6.0 kPa) PaCO 2 was associated with higher rSO 2 than low-normal (4.5-4.7 kPa) PaCO 2 in comatose resuscitated patients. A larger randomised trial (NCT03114033) comparing mild hypercarbia (6.7-7.3 kPa) with normocarbia after CA is currently ongoing.
Current limitations and future perspectives
The association between higher rSO 2 values during CPR and the rates of ROSC or neurological recovery suggests that rSO 2 could be used as a physiological target to optimise CPR quality. However, the nature of this association is not completely clear. In fact, since NIRS signals can be contaminated from extracerebral circulation [12] , rSO 2 values during CPR may reflect whole-body rather than brain perfusion. In addition, patients who achieve ROSC usually show higher rSO 2 values from the beginning of the resuscitation attempt [2] , so that it is not clear whether a higher rSO 2 in these patients reflects more effective CPR or, instead, other favourable factors, such as witnessed status or a shorter no-flow time.
Although lower nadir rSO 2 levels have been associated with worse neurological outcome in resuscitated comatose patients [13] , observational studies did not show an association between mean rSO 2 in the early post-resuscitation phase and neurological outcome. In the COMAC-ARE trial, changes in mean rSO 2 were not associated with differences in the levels of neuron-specific enolase, a marker of neuronal ischaemia. However, rSO 2 values were within normal values in all study groups. A limitation of this and other investigational models, such as the ones based on COX, is that the relationship between rSO 2 and CBF is not well known, although a recent study has shown that rSO 2 is positively correlated with cerebral perfusion pressure evaluated noninvasively using transcranial Doppler [14] . Further research is required to determine if cerebral oximetry is of real value in resuscitation, but based on current evidence it is not ready for routine clinical use. Optimal MAP is defined as the one which minimises the correlation coefficient (COX) between MAP and rSO 2 (optimal autoregulation) Observational evidence [8, 9, 11] showed that deviation from optimal MAP is associated with worse neurological outcome or lower survival in both children and adults
There are no interventional studies showing that targeting a specific MAP improves neurological outcome after CPR The relationships between rSO 2 , CBF and neurological outcome are not fully understood and deserve further investigation
